104 related articles for article (PubMed ID: 6715079)
1. Lorcainide kinetics and protein binding in patients with end-stage renal disease.
Somani P; Simon V; Gupta RK; King P; Shapiro RS; Stockard H
Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):121-5. PubMed ID: 6715079
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics and tissue distribution of the new antiarrhythmic agent lorcainide (R 15889) in rats.
Klotz U; Golbs E
Arzneimittelforschung; 1980; 30(4):619-21. PubMed ID: 7190402
[TBL] [Abstract][Full Text] [Related]
3. Effect of enzyme induction on the disposition of lorcainide in rats following intravenous and oral administration.
Plänitz V; Jähnchen E
Arzneimittelforschung; 1984; 34(6):669-71. PubMed ID: 6541487
[TBL] [Abstract][Full Text] [Related]
4. Disposition and antiarrhythmic effect of lorcainide.
Klotz U; Müller-Seydlitz P; Heimburg P
Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):152-8. PubMed ID: 376458
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiological characteristics of lorcainide, a new antiarrhythmic drug.
Solti F; Czakó E; Szatmáry L
Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):26-9. PubMed ID: 3957486
[TBL] [Abstract][Full Text] [Related]
6. Antiarrhythmic effect of lorcainide during chronic treatment.
Meinertz T; Kasper W; Kersting F; Bechtold H; Just H; Jähnchen E
Arzneimittelforschung; 1980; 30(9):1593-5. PubMed ID: 7193031
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of lorcainide, a new antiarrhythmic drug, in patients with cardiac rhythm disorders.
Somani P
Am J Cardiol; 1981 Jul; 48(1):157-63. PubMed ID: 7246437
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics of the initiation of antiarrhythmic therapy with lorcainide.
Winkle RA; Keefe DL; Rodriguez I; Kates RE
Am J Cardiol; 1984 Feb; 53(4):544-51. PubMed ID: 6198895
[TBL] [Abstract][Full Text] [Related]
9. Lorcainide disposition kinetics in arrhythmia patients.
Kates RE; Keefe DL; Winkle RA
Clin Pharmacol Ther; 1983 Jan; 33(1):28-34. PubMed ID: 6848296
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of alfentanil in chronic renal failure.
Chauvin M; Lebrault C; Levron JC; Duvaldestin P
Anesth Analg; 1987 Jan; 66(1):53-6. PubMed ID: 3099599
[TBL] [Abstract][Full Text] [Related]
11. [Clinical-electrophysiological study of the effect of lorcainide on induction of ventricular tachycardia (author's transl)].
Breithardt G; Seipel L; Abendroth RR
Z Kardiol; 1981 Jul; 70(7):530-5. PubMed ID: 7269732
[TBL] [Abstract][Full Text] [Related]
12. Prehepatic and hepatic first-pass metabolism of lorcainide in rats.
Plänitz V; Grönniger J; Jähnchen E
Arzneimittelforschung; 1985; 35(6):923-6. PubMed ID: 4026917
[TBL] [Abstract][Full Text] [Related]
13. [Preliminary clinical and experimental data on a new anti-arrhythmic drug: lorcainide].
Pretolani E; Battistini G; Iosa G; Mambelli M; Pigini G; Zoli I
Minerva Med; 1980 Apr; 71(13):975-80. PubMed ID: 7375011
[TBL] [Abstract][Full Text] [Related]
14. Lorcainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
Eiriksson Ce; Brogden RN
Drugs; 1984 Apr; 27(4):279-300. PubMed ID: 6373222
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the antiarrhythmic activity of mexiletine and lorcainide on ventricular arrhythmias.
Meinertz T; Kasper W; Stengel E; Waldecker B; Löllgen H; Jähnchen E; Bechtold H; Just J
Z Kardiol; 1982 Jan; 71(1):35-8. PubMed ID: 7039160
[TBL] [Abstract][Full Text] [Related]
16. Comparison in vitro of the electrophysiological effects of lorcainide and its metabolite norlorcainide.
Carmeliet E
Eur J Pharmacol; 1987 Jan; 133(1):29-36. PubMed ID: 3556390
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent.
Klotz U; Müller-Seydlitz P; Heimburg P
Clin Pharmacokinet; 1978; 3(5):407-18. PubMed ID: 699462
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
19. Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction.
Leinonen H; Heikkilä J; Sundberg S; Gordin A
Ann Clin Res; 1984; 16(1):18-22. PubMed ID: 6378045
[TBL] [Abstract][Full Text] [Related]
20. Resistant ventricular arrhythmias treated with lorcainide, a new antiarrhythmic drug.
Somani P; di Giorgi S
Chest; 1980 Oct; 78(4):658-60. PubMed ID: 7418495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
